Ophthotech Corp. to Report Fourth Quarter & Full Year 2016 Financial Results & Host Conference Call on Tuesday, February 28, ...
February 22 2017 - 7:30AM
Business Wire
Ophthotech Corporation (Nasdaq:OPHT) today announced that it
will report its fourth quarter and full year 2016 financial and
operating results on Tuesday, February 28, 2017. Following the
announcement, Ophthotech’s management team will host a live
conference call and webcast at 8:00 a.m. Eastern Time to discuss
the Company’s financial results and provide a general business
update.
To participate in this conference call, dial 888-286-2317 (USA)
or 719-325-2228 (International), passcode 2242489. A live,
listen-only audio webcast of the conference call can be accessed on
the Investor Relations section of the Ophthotech website at:
www.ophthotech.com. A replay will be available approximately two
hours following the live call for two weeks. The replay number is
888-203-1112 (USA Toll Free), passcode 2242489.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of novel therapeutics for diseases of the eye. For more
information, please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release about Ophthotech's future
expectations, plans and prospects constitute forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors. Any
forward-looking statements represent Ophthotech's views only as of
the date of this press release. Ophthotech anticipates that
subsequent events and developments will cause its views to change.
While Ophthotech may elect to update these forward-looking
statements at some point in the future, Ophthotech specifically
disclaims any obligation to do so.
OPHT-G
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170222005152/en/
InvestorsOphthotech CorporationKathy Galante,
212-845-8231Vice President, Investor Relations and Corporate
Communicationskathy.galante@ophthotech.comorMediaSmithSolve
LLC on behalf of Ophthotech CorporationAlex Van Rees, 973-442-1555
ext. 111alex.vanrees@smithsolve.com
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Mar 2024 to Apr 2024
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Apr 2023 to Apr 2024